Anthropic is operating a lab that conducts biology experiments

Anthropic has confirmed it operates a wet biology lab where its AI models are used to run physical experiments, according to Eric Kauderer-Abrams, Anthropic's head of life sciences, who told Reuters, "We absolutely are doing that today." The lab follows Anthropic's April acquisition of stealth AI biotech Coefficient Bio and the launch this week of a Life Sciences Verification Program giving vetted bio researchers access to its most powerful models; Anthropic declined to say what the wet lab is working on, except that it is not focused on drug discovery. The disclosure drew attention because CEO Dario Amodei has repeatedly called bioterrorism one of AI's biggest risks and last weekend published a post urging the industry to slow down and self-regulate, prompting investor Chamath Palihapitiya to post on X, "I do not recommend this.

Anthropic has confirmed that it has a wet biology lab where it can use its AI models to run physical experiments. AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: “I believe that AI could cure most major diseases in the next 5–10 years.” To do that, an LLM would have to have methods to test its theories in real life. “We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams told Reuters https://www.reuters.com/world/anthropic-quietly-sets-up-biology-lab-it-ramps-ai-drug-program-2026-09-18/ . “We absolutely are doing that today.” He added that the lab operates like most biotech labs: Anthropic conducts some research there while also working with externals partners. This news probably shouldn’t be shocking. Anthropic bought Coefficient Bio, a stealth AI biotech https://techcrunch.com/2026/04/03/anthropic-buys-biotech-startup-coefficient-bio-in-400m-deal-reports/ , in April. It declined to say what the wet lab is working on, except that it’s not focused on drug discovery. Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners. For instance, it just announced a deal to work with Novo Nordisk https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916768 on joint drug discovery. Anthropic has already faced backlash https://www.wsj.com/tech/ai/a-backlash-against-anthropic-is-brewing-in-silicon-valley-3b3ddc80 for launching products perceived to compete with those of its customers. To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access https://www.anthropic.com/news/life-sciences-verification-program to its most powerful models. But the world is still reeling from the resignation of Anthropic researcher Jacob Coxon, who warned that “the people building AI earnestly believe that it could kill us all by the end of the decade https://techcrunch.com/2026/09/09/gambling-with-our-lives-anthropic-researcher-quits-warns-against-self-improving-ai/ .” Anthropic’s own alignment lead gave the odds at greater than 10% https://x.com/EvanHub/status/2097497037956891126 that AI could exterminate humanity within the next decade. The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation. He has repeatedly called bioterrorism one of AI’s biggest risks. The juxtaposition of these dire warnings and the wet lab has not gone unnoticed in the tech industry. As investor and AI coding startup founder https://techcrunch.com/2026/06/29/chamath-palihapitiya-raises-135m-series-a-for-his-ai-coding-startup-takes-ceo-role/ Chamath Palihapitiya posted on X https://x.com/chamath/status/2100952390145094094 , somewhat tongue-in-cheek: “The group behind such hits as: “We’re All Going To Die” and “Regulate Me Now” are building a wet lab in SF. I do not recommend this.”